EUVIMEDOpdag EUVIMED
Crossref

Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer

Di Gao, Xinyu He, Liangliang Jia, Xinyuan Zhang, Liujiao Ren, Xuechun Ren, Xinyang Liu, Rong Yun, Zeyu Hu, Zhongmin Tian iD, Zhe Yang iD

ACS Nano · 2025-09-09 · 19 (35) · 31582-31597

DOI: 10.1021/acsnano.5c08856 ↗

At a glance

Journal article in ACS Nano, published online on 2025-08-28. Written by Di Gao and 10 co-authors. Institution: The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, …. Major MEDLINE topics: Prodrugs, Photosensitizing Agents, Deoxycytidine, Immunomodulation. Cited 11 times so far (Crossref); 40 references. Funded by: China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gemcitabine (GEM), an "old-school" chemotherapeutic agent, holds significant potential for repurposing due to its immunomodulatory properties, particularly in mitigating the immunosuppressive tumor microenvironment by depleting myeloid-derived suppressor cells and regulatory T cells. However, it is not regarded as an immunogenic agent, leaving a "cold" tumor state. Thus, we developed a carrier-free nanoprodrug that self-assembles from two zinc phthalocyanine (ZnPc)-based photosensitizer prodrugs, incorporating photodynamic therapy (PDT) to induce immunogenic cell death. A reactive oxygen species (ROS)-cleavable β-aminoacrylate linker (AA) was utilized to conjugate ZnPc and GEM, synthesizing the prodrug ZnPc-AA-GEM, which enables GEM release following ROS generation induced by PDT. Furthermore, the amphiphilic ZnPc-PEG enhances the stability and circulation time of the nanoprodrugs. These nanoprodrugs facilitate efficient tumor accumulation of GEM, activating its function through laser irradiation. Importantly, the combination of PDT and GEM increases tumor immunogenicity, enhancing effector T cell recruitment and mitigating tumor-associated immunosuppression, thereby amplifying the chemotherapeutic immunomodulatory effects of GEM. Comprehensive biosecurity evaluations indicated that carrier-free nanoprodrug exhibits minimal hemotoxicity and no significant adverse effects. Our study proposes a strategy that leverages traditional chemotherapeutics alongside advanced photodynamic approaches for more effective cancer treatment.

Subjects

MeSH terms (MEDLINE)

ProdrugsPhotosensitizing AgentsDeoxycytidineImmunomodulationAntineoplastic AgentsLasersNanoparticlesNeoplasmsAnimalsPhotochemotherapyIsoindolesMiceIndolesOrganometallic CompoundsHumansGemcitabineReactive Oxygen SpeciesCell Line, TumorMice, Inbred C57BLTumor MicroenvironmentZinc Compounds

Author keywords

carrier-free nanomedicinechemotherapeutic immunomodulationdrug repurposinggemcitabinephotodynamic therapyzinc phthalocyanine

Substances

ProdrugsIsoindolesPhotosensitizing AgentsIndolesDeoxycytidineZn(II)-phthalocyanineOrganometallic CompoundsGemcitabineAntineoplastic AgentsReactive Oxygen Species

Authors and institutions

  • The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
  • Research Institute of Xi'an Jiaotong University, Hangzhou 311200, China.

ORCID profiles: Zhongmin Tian, Zhe Yang

Funding

  • China Postdoctoral Science Foundation
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi Province
  • Natural Science Foundation of Zhejiang Province
  • Postdoctoral Science Foundation of Shaanxi Province
  • Shaanxi Province

Cite

APA

Gao, D., He, X., Jia, L., Zhang, X., Ren, L., Ren, X., Liu, X., Yun, R., Hu, Z., Tian, Z., & Yang, Z. (2025). Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer. ACS Nano, 19(35), 31582-31597. https://doi.org/10.1021/acsnano.5c08856

Vancouver

Gao D, He X, Jia L, Zhang X, Ren L, Ren X, et al. Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer. ACS Nano. 2025;19(35):31582-31597. doi:10.1021/acsnano.5c08856

BibTeX
@article{Gao2025,
  author = {Gao, Di and He, Xinyu and Jia, Liangliang and Zhang, Xinyuan and Ren, Liujiao and Ren, Xuechun and Liu, Xinyang and Yun, Rong and Hu, Zeyu and Tian, Zhongmin and Yang, Zhe},
  title = {Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {35},
  pages = {31582--31597},
  doi = {10.1021/acsnano.5c08856}
}
Start for free →